We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Efficacy of Systane Ultra to Stabilize the Tear Film in Dry Eye Subjects
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
A Phase 2, Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) Given in Combination With Lucentis in Subjects With Neovascular Age-Related Macular Degeneration
Status: Archived
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
Updated: 1/1/1970
A Phase 2, Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) Given in Combination With Lucentis in Subjects With Neovascular Age-Related Macular Degeneration
Status: Archived
Updated: 1/1/1970
Clinical Evaluation of a 1-Piece Intraocular Lens
Clinical Evaluation of the TECNIS® Toric 1-Piece Intraocular Lens
Status: Archived
Clinical Evaluation of a 1-Piece Intraocular Lens
Updated: 1/1/1970
Clinical Evaluation of the TECNIS® Toric 1-Piece Intraocular Lens
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Status: Archived
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Lens Metrology Study
Status: Archived
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
Status: Archived
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
Updated: 1/1/1970
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
Status: Archived
Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Confirmatory Study Nepafenac 0.3%
Status: Archived
Confirmatory Study Nepafenac 0.3%
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Status: Archived
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Status: Archived
Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension
Status: Archived
Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
AL-817 and AL-4943A for the Treatment of Allergic Conjunctivitis
Status: Archived
AL-817 and AL-4943A for the Treatment of Allergic Conjunctivitis
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema
Status: Archived
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema
Updated: 1/1/1970
A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema
Status: Archived
Updated: 1/1/1970
Evaluation of 3 Intraocular Lenses Following Lens Extraction
A Three Arm Prospective Clinical Evaluation of Three FDA Approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction.
Status: Archived
Evaluation of 3 Intraocular Lenses Following Lens Extraction
Updated: 1/1/1970
A Three Arm Prospective Clinical Evaluation of Three FDA Approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction.
Status: Archived
Updated: 1/1/1970
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
Status: Archived
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
Status: Archived
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
Updated: 1/1/1970
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
Status: Archived
Updated: 1/1/1970
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Status: Archived
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Updated: 1/1/1970
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Status: Archived
Updated: 1/1/1970
Patient Perception Study of AL-4943A
Status: Archived
Patient Perception Study of AL-4943A
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry Eye
Status: Archived
Effects of Cataract Extraction Surgery and Limbal Relaxing Incision on Corneal Sensation and Dry Eye
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
A Randomized, Double-Masked, Parallel-Group, Vehicle Controlled, Multicenter, Exploratory Study Assessing the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
Status: Archived
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
Updated: 1/1/1970
A Randomized, Double-Masked, Parallel-Group, Vehicle Controlled, Multicenter, Exploratory Study Assessing the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
Status: Archived
Updated: 1/1/1970
Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers
Status: Archived
Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients
A Prospective Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients
Status: Archived
An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients
Updated: 1/1/1970
A Prospective Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients
Status: Archived
Updated: 1/1/1970
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients
Status: Archived
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
An Open-Label Study of the Safety and Tolerability of Combining 20089 (Triamcinolone Acetonide Intravitreal Injection) When Used Adjunctively With Lucentis® 0.5 mg Intravitreal Injection in Subjects With Subfoveal Neovascular AMD
Status: Archived
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
Updated: 1/1/1970
An Open-Label Study of the Safety and Tolerability of Combining 20089 (Triamcinolone Acetonide Intravitreal Injection) When Used Adjunctively With Lucentis® 0.5 mg Intravitreal Injection in Subjects With Subfoveal Neovascular AMD
Status: Archived
Updated: 1/1/1970
Safety of Besivanceâ„¢ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle
A Study to Evaluate the Safety of Besivanceâ„¢ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle Following TID Dosing for 7 Days
Status: Archived
Safety of Besivanceâ„¢ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle
Updated: 1/1/1970
A Study to Evaluate the Safety of Besivanceâ„¢ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle Following TID Dosing for 7 Days
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
Safety Study of the VEGA UV-A System to Treat Keratoconus
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Safety Study of the VEGA UV-A System to Treat Keratoconus
Updated: 1/1/1970
Safety and Effectiveness of the VEGA UV-A System for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Archived
Updated: 1/1/1970
An Assessment of Residual Spherical Aberration Post-operative Total High Order Aberrations and Functional Vision Correlation After SN60WF Intraocular Lens (IOL) Implantation
An Assessment of Residual Spherical Aberration Post-operative Total High Order Aberrations and Functional Vision Correlation After SN60WF Intraocular Lens (IOL) Implantation
Status: Archived
An Assessment of Residual Spherical Aberration Post-operative Total High Order Aberrations and Functional Vision Correlation After SN60WF Intraocular Lens (IOL) Implantation
Updated: 1/1/1970
An Assessment of Residual Spherical Aberration Post-operative Total High Order Aberrations and Functional Vision Correlation After SN60WF Intraocular Lens (IOL) Implantation
Status: Archived
Updated: 1/1/1970
Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence
Comparative Study of Photopic and Mesopic Distance Intermediate and Near Visual Acuity, and Spectacle Independence With Binocular Implantation of the Tecnis Multifocal (TMF) Intraocular Lens or Crystalens HD (CHD) Intraocular Lens
Status: Archived
Comparative Study of Photopic and Mesopic Distance, Intermediate and Near Visual Acuity, and Spectacle Independence
Updated: 1/1/1970
Comparative Study of Photopic and Mesopic Distance Intermediate and Near Visual Acuity, and Spectacle Independence With Binocular Implantation of the Tecnis Multifocal (TMF) Intraocular Lens or Crystalens HD (CHD) Intraocular Lens
Status: Archived
Updated: 1/1/1970
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Updated: 1/1/1970
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Updated: 1/1/1970
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Updated: 1/1/1970
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Updated: 1/1/1970
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Updated: 1/1/1970
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Updated: 1/1/1970
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Updated: 1/1/1970
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Updated: 1/1/1970
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Updated: 1/1/1970
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Updated: 1/1/1970
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Updated: 1/1/1970
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolveâ„¢ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities
Status: Archived
Updated: 1/1/1970
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
Status: Archived
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A Single-Center Pilot Study to Assess Macular Function
Status: Archived
A Single-Center Pilot Study to Assess Macular Function
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
Status: Archived
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Surgical Treatment of Refractory Open Angle Glaucoma
Surgical Treatment of Refractory Open Angle Glaucoma - A Prospective, Open-Label, Pilot Study
Status: Archived
Surgical Treatment of Refractory Open Angle Glaucoma
Updated: 1/1/1970
Surgical Treatment of Refractory Open Angle Glaucoma - A Prospective, Open-Label, Pilot Study
Status: Archived
Updated: 1/1/1970
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1%
A Single-Center, Open-Label Study to Characterize Eyelid Margin Erythema, Markers of Clinical Inflammation and Levels of Inflammatory Mediators in the Lid Margins and Conjunctivae of Untreated Healthy Volunteers and Subjects Diagnosed With Posterior Blepharoconjunctivitis Following Dosing With Azithromycin Ophthalmic Solution, 1% for Four Weeks
Status: Archived
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1%
Updated: 1/1/1970
A Single-Center, Open-Label Study to Characterize Eyelid Margin Erythema, Markers of Clinical Inflammation and Levels of Inflammatory Mediators in the Lid Margins and Conjunctivae of Untreated Healthy Volunteers and Subjects Diagnosed With Posterior Blepharoconjunctivitis Following Dosing With Azithromycin Ophthalmic Solution, 1% for Four Weeks
Status: Archived
Updated: 1/1/1970